Significant changes in inflammatory markers such as C-reactive protein (CRP), procalcitonin, D-dimer, and lymphopenia have been described in people with pre-existing type 2 diabetes (T2DM), and notably in poorly managed T2DM with hyperglycemia [33]. This evidence concerns the gene CRP and Hyperglycemia.